Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Day One Biopharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
DAWN
Nasdaq
2836
dayonebio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Day One Biopharmaceuticals, Inc.
European OJEMDA Opinion Puts Spotlight On Day One Valuation And Momentum
- Mar 4th, 2026 6:12 pm
Day One Biopharmaceuticals Inc (DAWN) Q4 2025 Earnings Call Highlights: Record Revenue Growth ...
- Feb 24th, 2026 10:03 pm
Day One Biopharmaceuticals Q4 Earnings Call Highlights
- Feb 24th, 2026 9:11 pm
Day One Biopharmaceuticals, Inc. Q4 2025 Earnings Call Summary
- Feb 24th, 2026 6:04 pm
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Beats Revenue Estimates
- Feb 24th, 2026 5:30 pm
Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance
- Feb 24th, 2026 2:00 pm
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Feb 18th, 2026 8:00 am
Will Day One Biopharmaceuticals, Inc. (DAWN) Report Negative Earnings Next Week? What You Should Know
- Feb 17th, 2026 8:00 am
Is FMR’s 43% Stake Cut Reshaping the Investment Case for Day One Biopharmaceuticals (DAWN)?
- Feb 14th, 2026 8:14 pm
Examining Day One Biopharmaceuticals (DAWN) Valuation After Recent Share Moves And OJEMDA Growth Expectations
- Feb 14th, 2026 11:09 am
Has Celcuity (CELC) Outpaced Other Medical Stocks This Year?
- Feb 13th, 2026 7:40 am
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026
- Feb 10th, 2026 6:30 am
AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit
- Feb 3rd, 2026 3:20 pm
Wall Street Analysts See a 101.08% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High?
- Feb 2nd, 2026 7:55 am
A Look At Day One Biopharmaceuticals (DAWN) Valuation After Recent Share Price Momentum
- Jan 30th, 2026 7:10 pm
Best Momentum Stocks to Buy for January 27th
- Jan 27th, 2026 8:00 am
New Strong Buy Stocks for January 27th
- Jan 27th, 2026 2:16 am
Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 107.36%: Read This Before Placing a Bet
- Jan 15th, 2026 7:55 am
Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?
- Jan 13th, 2026 7:21 am
A Look At Day One Biopharmaceuticals (DAWN) Valuation After Strong OJEMDA Revenue And 2026 Outlook Updates
- Jan 13th, 2026 6:09 am
Scroll